Literature DB >> 26529523

Implications of BMI for the Prognosis of Gastric Cancer among the Japanese Population.

Tomoko Wada1, Chikara Kunisaki, Hidetaka Andrew Ono, Hirochika Makino, Hirotoshi Akiyama, Itaru Endo.   

Abstract

BACKGROUND: The clinical significance of body mass index (BMI) on the surgical outcomes in gastric cancer patients still remains controversial.
METHODS: The subjects included 427 patients who underwent gastrectomy between January 2001 and December 2005. The patients were principally divided into 3 groups on the basis of BMI: low (<18.5 kg/m2), normal (≥18.5-<25.0 kg/m2) and high (≥25.0 kg/m2).
RESULTS: The low-BMI patients had more advanced disease than the other patients. There were no statistically significant differences in the characteristics of the normal- and high-BMI patients. The operation time was longer in the high-BMI group, but there were no differences in terms of lymph node dissection and postoperative complications among these 3 groups. The overall survival and disease-specific survival of the low-BMI group were worse than the other 2 groups. These survival rates of high-BMI group tended to be better than those of the normal BMI group; however, it was not statistically different. A multivariate analysis of these survival rate showed that a low BMI was an independent predictor of a poor prognosis.
CONCLUSIONS: A low-BMI was an independent factor of poor prognosis for overall and disease-specific survivals after surgery in Japanese patients with gastric cancer. A high-BMI was not a risk factor.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26529523     DOI: 10.1159/000440654

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  8 in total

1.  Overweight or Obesity is an Unfavorable Long-Term Prognostic Factor for Patients who Underwent Gastrectomy for Stage II/III Gastric Cancer.

Authors:  Yuichi Kambara; Norihiro Yuasa; Eiji Takeuchi; Hideo Miyake; Hidemasa Nagai; Yuichiro Yoshioka; Masataka Okuno; Kanji Miyata
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

2.  Advanced lung cancer inflammation index (ALI) predicts prognosis of patients with gastric cancer after surgical resection.

Authors:  Xin Zhang; Danfang Wang; Tuanhe Sun; Wenxing Li; Chengxue Dang
Journal:  BMC Cancer       Date:  2022-06-21       Impact factor: 4.638

3.  Prospective study on factors affecting the prognosis of oral cancer in a Chinese population.

Authors:  Fengqiong Liu; Fa Chen; Jiangfeng Huang; Lingjun Yan; Fangping Liu; Junfeng Wu; Yu Qiu; Xiaoyan Zheng; Rongzhao Zhang; Lisong Lin; Baochang He
Journal:  Oncotarget       Date:  2017-01-17

4.  Impact of body mass index on surgical outcomes of gastric cancer.

Authors:  Fan Feng; Gaozan Zheng; Xiaohua Guo; Zhen Liu; Guanghui Xu; Fei Wang; Qiao Wang; Man Guo; Xiao Lian; Hongwei Zhang
Journal:  BMC Cancer       Date:  2018-02-06       Impact factor: 4.430

5.  The Impact of Preoperative Low Body Mass Index on Postoperative Complications and Long-term Survival Outcomes in Gastric Cancer Patients.

Authors:  Chang Hyun Kim; Seung-Man Park; Jin-Jo Kim
Journal:  J Gastric Cancer       Date:  2018-09-14       Impact factor: 3.720

6.  The Incidence of Postoperative Complications after Gastrectomy Increases in Proportion to the Amount of Preoperative Visceral Fat.

Authors:  Kazuyuki Okada; Tatsuto Nishigori; Kazutaka Obama; Shigeru Tsunoda; Koya Hida; Shigeo Hisamori; Yoshiharu Sakai
Journal:  J Oncol       Date:  2019-12-16       Impact factor: 4.375

7.  Effect of Time (Season, Surgical Starting Time, Waiting Time) on Patients with Gastric Cancer.

Authors:  Dong Peng; Ying-Ying Zou; Yu-Xi Cheng; Wei Tao; Wei Zhang
Journal:  Risk Manag Healthc Policy       Date:  2021-03-29

8.  Body mass index and skeletal muscle index are useful prognostic factors for overall survival after gastrectomy for gastric cancer: Retrospective cohort study.

Authors:  Eun Young Kim; Kyong Hwa Jun; Shinn Young Kim; Hyung Min Chin
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.